Showing results (91-100 of 141) with videos related to

Sort By:
Pageof 15
Core Evidence|April 14, 2012
FTY720 in multiple sclerosis: the emerging evidence of its therapeutic valueAndrew Thomson
Core Evidence|October 4, 2014
Colistimethate sodium for the treatment of chronic pulmonary infection in cystic fibrosis: an evidence-based review of its place in therapyCordula Koerner-Rettberg, Manfred Ballmann
Core Evidence|August 13, 2014
Regorafenib: an evidence-based review of its potential in patients with advanced liver cancerSujan Ravi, Ashwani K Singal
Core Evidence|November 7, 2019
Anabolics in the management of glucocorticoid-induced osteoporosis: an evidence-based review of long-term safety, efficacy and place in therapyAdam D Taylor, Kenneth G Saag
Core Evidence|July 25, 2012
An evidence-based review of apixaban and its potential in the prevention of stroke in patients with atrial fibrillationPrakash Deedwania, Grace W Huang
Core Evidence|November 3, 2012
Polifeprosan 20, 3.85% carmustine slow-release wafer in malignant glioma: evidence for role in era of standard adjuvant temozolomideLawrence Kleinberg
Core Evidence|February 25, 2015
Oritavancin for the treatment of acute bacterial skin and skin structure infections: an evidence-based reviewJoumana Kmeid, Zeina A Kanafani
Core Evidence|July 23, 2013
Lixivaptan - an evidence-based review of its clinical potential in the treatment of hyponatremiaBrendan T Bowman, Mitchell H Rosner
Core Evidence|April 13, 2012
Fosphenytoin for the treatment of status epilepticus: an evidence-based assessment of its clinical and economic outcomesAndrew Thomson
Core Evidence|June 10, 2011
Emerging role of carfilzomib in treatment of relapsed and refractory lymphoid neoplasms and multiple myelomaSalvia Jain, Catherine Diefenbach, Jasmine Zain, et al.
Pageof 15